From: Association between acute stroke and COVID-19 infection among patients with acute stroke
Variable | COVID-19 infection | P value | ||||
---|---|---|---|---|---|---|
No | Mild | Moderate | Severe | |||
Age | Mean ± SD | 52.7 ± 15.2 | 55.6 ± 12.9 | 62.2 ± 12.1 | 69.1 ± 12.3 | < 0.001* |
Gender | Male, n (%) | 114 (60.3) | 44 (60.3) | 26 (38.8) | 20 (38.5) | 0.001* |
Female, n (%) | 75 (39.7) | 29 (39.7) | 41 (61.2) | 32 (61.5) | ||
HTN | Yes, n (%) | 53 (28) | 35 (47.9) | 28 (41.8) | 31 (59.6) | < 0.001* |
No, n (%) | 136 (72) | 38 (52.1) | 39 (58.2) | 21 (40.4) | ||
DM | Yes, n (%) | 48 (25.4) | 20 (27.4) | 23 (34.3) | 30 (57.7) | < 0.001* |
No, n (%) | 141 (74.6) | 53 (72.6) | 44 (65.7) | 22 (42.3) | ||
Hyperthyroidism | Yes, n (%) | 6 (3.2) | 5 (6.8) | 4 (6.0) | 3 (5.8) | 0.552 |
No, n (%) | 183 (96.8) | 68 (93.2) | 63 (94.0) | 49 (94.2) | ||
Cardiac | Yes, n (%) | 36 (19) | 23 (31.5) | 29 (43.3) | 34 (65.4) | < 0.001* |
No, n (%) | 153 (81) | 50 (68.5) | 38 (56.7) | 18 (34.6) | ||
AF, n (%) | 9 (2.4) | 11 (2.9) | 8 (2.1) | 10 (2.6) | ||
IHD, n (%) | 16 (4.2) | 14 (3.7) | 17 (4.5) | 19 (4.9) | ||
CMP, n (%) | 3 (0.8) | 4 (1.0) | 6 (1.6) | 5 (1.3) | ||
Renal/hepatic | Yes, n (%) | 16 (8.5) | 4 (5.5) | 7 (10.4) | 9 (17.3) | 0.145 |
No, n (%) | 173 (91.5) | 69 (94.5) | 60 (89.6) | 43 (82.7) | ||
Hypercholesteremia | Yes, n (%) | 49 (25.9) | 21 (28.8) | 25 (37.3) | 18 (34.6) | 0.286 |
No, n (%) | 140 (74.1) | 52 (71.2) | 42 (62.7) | 34 (65.4) | ||
Obesity | Yes, n (%) | 56 (29.6) | 13 (82.2) | 17 (25.4) | 10 (19.2) | 0.167 |
No, n (%) | 133 (70.4) | 60 (82.2) | 50 (74.6) | 42 (80.8) | ||
Chronic vascular CNS problems Hemorrhagic, n (%) 29 (7.6) Ischemic, n (%) 61 (16.0) Venous, n (%) 3 (0.8) | Yes, n (%) | 34 (18.0) | 15 (20.5) | 21 (31.3) | 23 (44.2) | 0.001* |
No, n (%) | 155 (82.0) | 58 (79.5) | 46 (68.7) | 29 (55.8) | ||
D-dimer (µg/ml) | 0.8 ± 0.4 | 1.1 ± 0.6 | 1.2 ± 0.7 | 1.5 ± 0.8 | 0.001* | |
ICU admission | Yes, n (%) | 0 (0) | 0 (0) | 51 (98.1) | 0.001* | |
No, n (%) | 73 (100) | 67 (100) | 1 (1.9) |